Effect of Interleukin 6 Deficiency on Renal Interstitial Fibrosis

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Yang, Jun ^a,b   Chen, Jiyuan ^a   Yan, Jingyin ^a   Zhang, Liping ^a   Chen, Gang ^c   He, Liqun ^c   Wang, Yanlin ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c Shuguang Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CHEMOKINE; CYTOKINE; INTERLEUKIN 6; SCLEROPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CELL COUNT; CELL MATURATION; CELL TRANSPORT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE ASSOCIATION; FIBROBLAST; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; KIDNEY FIBROSIS; KIDNEY INJURY; MOUSE; MYOFIBROBLAST; NONHUMAN; PATHOGENESIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING;

ANIMALS; CHEMOKINE CXCL6; COLLAGEN TYPE I; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX PROTEINS; FIBROBLASTS; FIBRONECTINS; FIBROSIS; INTERLEUKIN-6; KIDNEY DISEASES; MALE; MICE; MICE, KNOCKOUT; MYELOID CELLS; MYOFIBROBLASTS;

MURINAE; MUS;

EID: 84871315578     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052415     Document Type: Article

References (38)

1. Schainuck LI, Striker GE, Cutler RE, Benditt EP, (1970) Structural-functional correlations in renal disease. II. The correlations. Hum Pathol 1: 631-641.
2. Nath KA, (1998) The tubulointerstitium in progressive renal disease. Kidney Int 54: 992-994.
3. Eddy AA, (2000) Molecular basis of renal fibrosis. Pediatr Nephrol 15: 290-301.
4. Neilson EG, (2006) Mechanisms of disease: Fibroblasts-a new look at an old problem. Nat Clin Pract Nephrol 2: 101-108.
5. Strutz F, Muller GA, (2006) Renal fibrosis and the origin of the renal fibroblast. Nephrol Dial Transplant 21: 3368-3370.
6. Liu Y, (2006) Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 69: 213-217.
7. Sakai N, Wada T, Yokoyama H, Lipp M, Ueha S, et al. (2006) Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci U S A 103: 14098-14103.
8. Grimm PC, Nickerson P, Jeffery J, Savani RC, Gough J, et al. (2001) Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection. N Engl J Med 345: 93-97.
9. Broekema M, Harmsen MC, van Luyn MJ, Koerts JA, Petersen AH, et al. (2007) Bone marrow-derived myofibroblasts contribute to the renal interstitial myofibroblast population and produce procollagen I after ischemia/reperfusion in rats. J Am Soc Nephrol 18: 165-175.
10. Chen G, Lin SC, Chen J, He L, Dong F, et al. (2011) CXCL16 recruits bone marrow-derived fibroblast precursors in renal fibrosis. Journal of the American Society of Nephrology: JASN 22: 1876-1886.
11. Li J, Deane JA, Campanale NV, Bertram JF, Ricardo SD, (2007) The contribution of bone marrow-derived cells to the development of renal interstitial fibrosis. Stem Cells 25: 697-706.
12. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A, (1994) Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1: 71-81.
13. Niedermeier M, Reich B, Rodriguez Gomez M, Denzel A, Schmidbauer K, et al. (2009) CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes. Proc Natl Acad Sci U S A 106: 17892-17897.
14. Shao DD, Suresh R, Vakil V, Gomer RH, Pilling D, (2008) Pivotal Advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. Journal of leukocyte biology 83: 1323-1333.
15. Haudek SB, Trial J, Xia Y, Gupta D, Pilling D, et al. (2008) Fc receptor engagement mediates differentiation of cardiac fibroblast precursor cells. Proc Natl Acad Sci U S A 105: 10179-10184.
16. Metz CN, (2003) Fibrocytes: a unique cell population implicated in wound healing. Cell Mol Life Sci 60: 1342-1350.
17. Quan TE, Cowper S, Wu SP, Bockenstedt LK, Bucala R, (2004) Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 36: 598-606.
18. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN, (2001) Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 166: 7556-7562.
19. Cieslik KA, Taffet GE, Carlson S, Hermosillo J, Trial J, et al. (2011) Immune-inflammatory dysregulation modulates the incidence of progressive fibrosis and diastolic stiffness in the aging heart. Journal of molecular and cellular cardiology 50: 248-256.
20. Gadient RA, Patterson PH, (1999) Leukemia inhibitory factor, Interleukin 6, and other cytokines using the GP130 transducing receptor: roles in inflammation and injury. Stem Cells 17: 127-137.
21. Pecoits-Filho R, Lindholm B, Axelsson J, Stenvinkel P, (2003) Update on interleukin-6 and its role in chronic renal failure. Nephrol Dial Transplant 18: 1042-1045.
22. Border WA, Noble NA, (1994) Transforming growth factor beta in tissue fibrosis. N Engl J Med 331: 1286-1292.
23. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E, (1990) Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature 346: 371-374.
24. Bottinger EP, Bitzer M, (2002) TGF-beta signaling in renal disease. Journal of the American Society of Nephrology: JASN 13: 2600-2610.
25. Lan HY, (2011) Diverse roles of TGF-beta/Smads in renal fibrosis and inflammation. International journal of biological sciences 7: 1056-1067.
26. Kielar ML, John R, Bennett M, Richardson JA, Shelton JM, et al. (2005) Maladaptive role of IL-6 in ischemic acute renal failure. J Am Soc Nephrol 16: 3315-3325.
27. Nechemia-Arbely Y, Barkan D, Pizov G, Shriki A, Rose-John S, et al. (2008) IL-6/IL-6R axis plays a critical role in acute kidney injury. J Am Soc Nephrol 19: 1106-1115.
28. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, et al. (1999) Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol 277: C1-9.
29. Eddy AA, (2005) Progression in chronic kidney disease. Advances in chronic kidney disease 12: 353-365.
30. Zhang G, Moorhead PJ, el Nahas AM, (1995) Myofibroblasts and the progression of experimental glomerulonephritis. Experimental nephrology 3: 308-318.
31. Roberts IS, Burrows C, Shanks JH, Venning M, McWilliam LJ, (1997) Interstitial myofibroblasts: predictors of progression in membranous nephropathy. Journal of clinical pathology 50: 123-127.
32. Essawy M, Soylemezoglu O, Muchaneta-Kubara EC, Shortland J, Brown CB, et al. (1997) Myofibroblasts and the progression of diabetic nephropathy. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association 12: 43-50.
33. Matloubian M, David A, Engel S, Ryan JE, Cyster JG, (2000) A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 1: 298-304.
34. Garcia GE, Truong LD, Li P, Zhang P, Johnson RJ, et al. (2007) Inhibition of CXCL16 attenuates inflammatory and progressive phases of anti-glomerular basement membrane antibody-associated glomerulonephritis. Am J Pathol 170: 1485-1496.
35. Zhang L, Ran L, Garcia GE, Wang XH, Han S, et al. (2009) Chemokine CXCL16 regulates neutrophil and macrophage infiltration into injured muscle, promoting muscle regeneration. Am J Pathol 175: 2518-2527.
36. Cheever AW, Williams ME, Wynn TA, Finkelman FD, Seder RA, et al. (1994) Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. Journal of immunology 153: 753-759.
37. Finkelman FD, Wynn TA, Donaldson DD, Urban JF, (1999) The role of IL-13 in helminth-induced inflammation and protective immunity against nematode infections. Current opinion in immunology 11: 420-426.
38. Wynn TA, (2008) Cellular and molecular mechanisms of fibrosis. J Pathol 214: 199-210.